ILAXTEN

This brand name is authorized in United Kingdom, South Africa

Active ingredients

The drug ILAXTEN contains one active pharmaceutical ingredient (API):

1 Bilastine UNII PA1123N395 - BILASTINE

Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral Η1 receptor antagonist affinity and no affinity for muscarinic receptors. Read about Bilastine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ILAXTEN Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AX29	Bilastine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX29

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 187493, 389194, 389198
Country: ZA	Health Products Regulatory Authority	Identifier(s): 52/5.7.1/0120